CareRx (TSE:CRRX) has released an update.
CareRx Corporation, a leading pharmacy services provider to seniors in Canada, has received Toronto Stock Exchange approval to renew its normal course issuer bid, allowing for the purchase and cancellation of up to 1.5 million shares. This bid, starting on September 7, 2024, represents about 2.5% of its outstanding shares and follows a previous bid where the company acquired shares at an average price of $2.13.
For further insights into TSE:CRRX stock, check out TipRanks’ Stock Analysis page.
